	Candidiasis
Drug therapy
Voriconazole
Antifungals
Prophylaxis
Aspergillosis
Fungal infection
	invasive fungal infections
clinical trials
voriconazole
cases
investigator
clinical evidence
treatment
patients
criteria
adverse events
favorable response
clinical decision-making
malignant hematological diseases
empirical therapy
indication
infection
IFI
probable
frequent
multi-centre survey
secondary
disease
Table
electronic data
invasive pulmonary aspergillosis
therapy
evidence
activity
efficacy
toxicity

